XOMA Royalty (XOMA) Invested Capital (2010 - 2026)
XOMA Royalty's (XOMA) quarterly Invested Capital came in at $106.9 million in Q1 2026, up 36.5% year-on-year from $78.3 million in Q1 2025, and up 10.8% quarter-over-quarter from $96.5 million in Q4 2025.
XOMA Royalty (XOMA) Invested Capital (2010 - 2026) Analysis & Trends
XOMA Royalty has disclosed Invested Capital across 17 years of filings, most recently posting $106.9 million for Q1 2026.
- Invested Capital for Q1 2026 came in at $106.9 million, up 36.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $106.9 million (up 36.5% YoY), and the FY2025 annual result was $96.5 million, up 31.61% from the prior year.
- Invested Capital came in at $106.9 million for Q1 2026 at XOMA Royalty, up from $96.5 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $139.9 million in Q1 2022 to a low of $68.5 million in Q1 2024.
- The 5-year median for Invested Capital is $102.3 million (2025), against an average of $100.2 million.
- Across the five-year window, Invested Capital soared 57.36% in 2022 and sank 40.22% in 2024, its largest moves.
- XOMA Royalty's Invested Capital stood at $124.0 million in 2022, then slumped by 40.13% to $74.2 million in 2023, then decreased by 1.28% to $73.3 million in 2024, then jumped by 31.61% to $96.5 million in 2025, then rose by 10.8% to $106.9 million in 2026.
- The last three Invested Capital figures came in at $106.9 million (Q1 2026), $96.5 million (Q4 2025), and $102.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 14.38 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 502.95 Mn |
| 10 | XOMA Royalty | 5.52 Mn | -60.56 Mn | - | 106.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106.89 Mn |
| Dec 31, 2025 | 96.47 Mn |
| Sep 30, 2025 | 102.28 Mn |
| Jun 30, 2025 | 84.11 Mn |
| Mar 31, 2025 | 78.31 Mn |
| Dec 31, 2024 | 73.30 Mn |
| Sep 30, 2024 | 74.62 Mn |
| Jun 30, 2024 | 85.69 Mn |
| Mar 31, 2024 | 68.47 Mn |
| Dec 31, 2023 | 74.25 Mn |
| Sep 30, 2023 | 105.96 Mn |
| Jun 30, 2023 | 110.12 Mn |
| Mar 31, 2023 | 114.53 Mn |
| Dec 31, 2022 | 124.01 Mn |
| Sep 30, 2022 | 130.33 Mn |
| Jun 30, 2022 | 134.96 Mn |
| Mar 31, 2022 | 139.92 Mn |
| Dec 31, 2021 | 141.88 Mn |
| Sep 30, 2021 | 111.58 Mn |
| Jun 30, 2021 | 116.58 Mn |